This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Amyris
AMRS
$0.07950
Share price
0.00%
Change (1 day)
-97.12%
Change (1 year)
EPS for Amyris (AMRS)
EPS in 2023 (TTM): -$2.73
According to Amyris's latest financial reports the company's current EPS (TTM) is -$2.91. In 2022 the company made an earnings per share (EPS) of -$2.61 a decrease over its 2021 EPS that were of -$1.59.
EPS history for Amyris from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.73 | 4.57% |
| 2022 | -$2.61 | 64% |
| 2021 | -$1.59 | -48.19% |
| 2020 | -$3.07 | -30.82% |
| 2019 | -$4.44 | -22.28% |
| 2018 | -$5.71 | -2.45% |
| 2017 | -$5.85 | -29.9% |
| 2016 | -$8.35 | -82.76% |
| 2015 | -$48.42 | -6866.68% |
| 2014 | $0.72 | -100.97% |
| 2013 | -$73.93 | -17.33% |
| 2012 | -$89.44 | -6.02% |
| 2011 | -$95.16 | -79.68% |
| 2010 | -$468.29 | 49.59% |
| 2009 | -$313.06 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$13.55 | 365.57% | 🇺🇸 USA |
 | $45.09 | -1,649.73% | 🇺🇸 USA |
 | $1.51 | -151.91% | 🇺🇸 USA |
 | -$3.77 | 29.51% | 🇺🇸 USA |
 | -$0.68 | -76.50% | 🇺🇸 USA |
 | $15.41 | -629.51% | 🇺🇸 USA |